Inventor · disambiguated record
Gary Musso
Also filed as: MUSSO GARY · MUSSO GARY F · MUSSO GARY FRED
35 granted patents·17 pending applications·2,646 citations·filing 1984–2024
98Inventor score
Files withPRAECIS PHARM INC20CENTREXION THERAPEUTICS CORP8SAFEWHITE INC4SALK INST BIOTECH IND4SISKA DIAGNOSTICS INC4
Top patents by PatentIndex Score
52 records- 0198US5506206AIncreasing blood-brain barrier permeability with permeabilizer peptidesALKERMES INC·Filed 1993·Granted Apr 9, 1996·481 cites·4 claims
- 0298US5268164AIncreasing blood-brain barrier permeability with permeabilizer peptidesALKERMES INC·Filed 1991·Granted Dec 7, 1993·539 cites·7 claims
- 0396US11344516B2Stable aqueous capsaicin injectable formulations and medical uses thereofCENTREXION THERAPEUTICS CORP·Filed 2020·Granted May 31, 2022·3 cites·32 claims
- 0496US10493047B2Stable aqueous capsaicin injectable formulations and medical uses thereofCENTREXION THERAPEUTICS CORP·Filed 2019·Granted Dec 3, 2019·8 cites·30 claims
- 0596US5854204AAβ peptides that modulate β-amyloid aggregationPRAECIS PHARM INC·Filed 1996·Granted Dec 29, 1998·230 cites·10 claims
- 0696US5686416AIncreasing blood-brain barrier permeability with permeabilizer peptidesALKERMES INC·Filed 1992·Granted Nov 11, 1997·252 cites·8 claims
- 0795US10772853B2Stable aqueous capsaicin injectable formulations and medical uses thereofCENTREXION THERAPEUTICS CORP·Filed 2019·Granted Sep 15, 2020·5 cites·30 claims
- 0895US10765649B2Stable aqueous capsaicin injectable formulations and medical uses thereofCENTREXION THERAPEUTICS CORP·Filed 2019·Granted Sep 8, 2020·5 cites·30 claims
- 0995US6180608B1Pharmaceutical formulations for sustained drug deliveryPRAECIS PHARM INC·Filed 1997·Granted Jan 30, 2001·119 cites·50 claims
- 1094US11000490B2Stable aqueous capsaicin injectable formulations and medical uses thereofCENTREXION THERAPEUTICS CORP·Filed 2017·Granted May 11, 2021·4 cites·13 claims
- 1194US5968895APharmaceutical formulations for sustained drug deliveryPRAECIS PHARM INC·Filed 1996·Granted Oct 19, 1999·109 cites·32 claims
- 1293US5854215AModulators of β-amyloid peptide aggregationPRAECIS PHARM INC·Filed 1995·Granted Dec 29, 1998·126 cites·38 claims
- 1393US5817626AModulators of beta-amyloid peptide aggregationPRAECIS PHARM INC·Filed 1995·Granted Oct 6, 1998·156 cites·27 claims
- 1492US6303567B1Modulators of β-amyloid peptide aggregation comprising D-amino acidsPRAECIS PHARM INC·Filed 1996·Granted Oct 16, 2001·142 cites·135 claims
- 1592US5985242AModulators of β-amyloid peptide aggregation comprising D-amino acidsPRAECIS PHARM INC·Filed 1997·Granted Nov 16, 1999·120 cites·19 claims
- 1690US7598343B1Pharmaceutical formulations of bivalirudin and processes of making the sameMEDICINES CO·Filed 2008·Granted Oct 6, 2009·14 cites·20 claims
- 1790US7582727B1Pharmaceutical formulations of bivalirudin and processes of making the sameMEDICINCES COMPANY·Filed 2008·Granted Sep 1, 2009·16 cites·20 claims
- 1890US6319498B1Modulators of amyloid aggregationPRAECIS PHARM INC·Filed 1996·Granted Nov 20, 2001·71 cites·52 claims
- 1989US2024423931A1Stable aqueous capsaicin injectable formulations and medical uses thereofCENTREXION THERAPEUTICS CORP·Filed 2024·Application pending·0 cites
- 2085US6689752B2Modulators of β-amyloid peptide aggregation comprising D-amino acidsPRAECIS PHARM INC·Filed 2001·Granted Feb 10, 2004·17 cites·21 claims
- 2184US6277826B1Modulators of β-amyloid peptide aggregation comprising D-amino acidsPRAECIS PHARM INC·Filed 1999·Granted Aug 21, 2001·36 cites·11 claims
- 2284US5130446AFluorescent compounds for tagging nucleic acid probesSISKA DIAGNOSTICS INC·Filed 1989·Granted Jul 14, 1992·20 cites·3 claims
- 2383US4833251ACompounds for tagging nucleic acid probesSISKA DIAGNOSTICS INC·Filed 1987·Granted May 23, 1989·36 cites·9 claims
- 2482US11992470B2Stable aqueous capsaicin injectable formulations and medical uses thereofCENTREXION THERAPEUTICS CORP·Filed 2022·Granted May 28, 2024·0 cites·20 claims
- 2582US5210203ASulfonamide-derivative compounds for tagging nucleic acid probesSISKA DIAGNOSTICS INC·Filed 1992·Granted May 11, 1993·22 cites·3 claims
- 2679US7175828B2Modulators of β-amyloid peptide aggregation comprising D-amino acidsPRAECIS PHARM INC·Filed 2003·Granted Feb 13, 2007·4 cites·13 claims
- 2778US9937120B2Polyelectrolyte dental adhesives for whitening teeth and teeth componentsSAFEWHITE INC·Filed 2017·Granted Apr 10, 2018·2 cites·17 claims
- 2878US4835252AVasoactive intestinal peptide analogsSALK INST BIOTECH IND·Filed 1987·Granted May 30, 1989·34 cites·12 claims
- 2975US7658917B2Modulators of amyloid aggregationPRAECIS PHARM INC·Filed 2003·Granted Feb 9, 2010·5 cites·20 claims
- 3069US6699833B1Pharmaceutical formulations for sustained drug deliveryPRAECIS PHARM INC·Filed 1999·Granted Mar 2, 2004·17 cites·36 claims
- 3169US2011009343A1Modulators of amyloid aggregationPRAECIS PHARM INC·Filed 2009·Application pending·0 cites
- 3269US2020206166A1Methods and compositions for treatment of pain using capsaicinCENTREXION THERAPEUTICS CORP·Filed 2018·Application pending·0 cites
- 3367US4780405ACarbonic anhydrase inhibitor-tagged nucleic acid probesSISKA DIAGNOSTICS INC·Filed 1985·Granted Oct 25, 1988·27 cites·20 claims
- 3463US2008032896A1Methods for identifying compounds that bind to a targetBENJAMIN HOWARD·Filed 2007·Application pending·0 cites
- 3563US2004091904A1Methods for identifying compounds that bind to a targetFiled 2003·Application pending·0 cites
- 3661US2019274945A1Polyelectrolyte dental adhesives for whitening teeth and teeth componentsSAFEWHITE INC·Filed 2018·Application pending·0 cites
- 3760US10201491B2Polyelectrolyte dental adhesives for whitening teeth and teeth componentsSAFEWHITE INC·Filed 2018·Granted Feb 12, 2019·0 cites·50 claims
- 3860US4939224AVasoactive intestinal peptide analogsSALK INST BIOTECH IND·Filed 1988·Granted Jul 3, 1990·24 cites·5 claims
- 3958US2020368136A1Polyelectrolyte dental adhesives for whitening teeth and teeth componentsSAFEWHITE INC·Filed 2020·Application pending·0 cites
- 4057US12337024B2Larazotide formulationsINTERLUDE BIOPHARMA CO·Filed 2020·Granted Jun 24, 2025·0 cites·17 claims
- 4156US2001006778A1Methods for identifying compounds that bind to a targetPRAECIS PHARM INC·Filed 2001·Application pending·0 cites
- 4255US2007248996A1Modulators of beta-amyloid peptide aggregation comprising D-amino acidsPARAECIS PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 4353US2005112087A1Pharmaceutical formulations for sustained drug deliveryFiled 2004·Application pending·0 cites
- 4452US2007185032A1Pharmaceutical formulations for sustained drug deliveryPRAECIS PHARM INC·Filed 2005·Application pending·0 cites
- 4552US2002098173A1Modulators of amyloid aggregationPRAECIS PHARM INC·Filed 2001·Application pending·0 cites
- 4652US2007185033A1Pharmaceutical formulations for sustained drug deliveryPRAECIS PHARM INC·Filed 2005·Application pending·0 cites
- 4750US2006193825A1Pharmaceutical formulations for sustained drug deliveryPRAECIS PHAMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 4850US2006177417A1Pharmaceutical formulations for sustained drug deliveryPRAECIS PHARM INC·Filed 2005·Application pending·0 cites
- 4950US2003171296A1Pharmaceutical formulations for sustained drug deliveryPRAECIS PHARM INC·Filed 2000·Application pending·0 cites
- 5034US4731412AProcess and composition for amino-terminal, α-aspartyl and α-glutamyl dipeptide estersSALK INST BIOTECH IND·Filed 1986·Granted Mar 15, 1988·2 cites·6 claims
Showing the top 50 of 52 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →